Since 1984, we’ve invested $75 million in the research that has made today’s breakthroughs possible. We advance a comprehensive research program, attacking SMA from all sides.

Our Strategy

Our approach includes four research areas—basic research, drug discovery, clinical trials, and clinical care—working together toward our vision of a world without SMA. READ MORE

Read More

Latest Advances

Read more about the SMA drug pipeline and other major developments in research. READ MORE

Read More

For Researchers

Researchers can apply for funding opportunities, attend the SMA Research Group Meeting, or request assistance in recruiting for clinical trials. READ MORE

Read More

Research Publications

Browse past issues of Compass, our quarterly research newsletter, and other relevant publications. READ MORE

Read More

© 2019 Cure SMA | Cure SMA is recognized as tax-exempt under section 501(c)(3) of the Internal Revenue Code. EIN: 36-3320440. | Privacy Policy

Powered by Blackbaud
nonprofit software